Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia 1Hyperglycemia 1Burkitt Lymphoma 1

Interventions

Insulin Glargine 4Insulin 3Alpelisib 3volagidemab 2Metformin 2Fulvestrant 2ziprasidone 1relacorilant 1pembrolizumab 1olaparib 1exemestane 1dapagliflozin 1Vildagliptin 1Tamoxifen 1Standard of Care 1Olanzapine 1Letrozole 1Insulin Lispro 1Insulin Aspart 1Injections 1Electrocardiography 1DNA, Ribosomal 1Control Groups 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hyperglycemia × Insulin Aspart × Clear all
NCT00500240 2015-06-03

Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)

M.D. Anderson Cancer Center

Phase 3 Terminated
52 enrolled 8 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hyperglycemia, Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡